Early response assessment of induction chemotherapy in acute myeloid leukemia patients using F-18 fluorodeoxythymidine (FLT) positron emission tomography (PET)/computed tomogrpahy (CT)

Not Applicable

Completed

• Conditions: Diseases of the blood and blood -forming organs and certain disorders involving the immune mechanism

• Registration Number: KCT0001293
• Lead Sponsor: The Catholic University of Korea, St. Vincent's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 March 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 13

Inclusion Criteria

Acute myeloid leukemia patients who is receiving induction chemotherapy
adults over 20 years of age
Persones who signed informed consents

Exclusion Criteria

Pregnancy
Beast feeding

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
performance of F-18 fluorodeoxythymidine (FLT) positron emission tomography (PET)/computed tomogrpahy (CT) in response assessment of induction chemotherapy

Secondary Outcome Measures

Name	Time	Method
correlation between F-18 fluorodeoxythymidine (FLT) positron emission tomography (PET)/computed tomogrpahy (CT) findings and known prognostic factors